Fingerprint
Dive into the research topics of 'Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors
Victoria Roulstone, Khurum Khan, Hardev S. Pandha, Sarah Rudman, Matt Coffey, George M. Gill, Alan A. Melcher, Richard Vile, Kevin J. Harrington, Johann De Bono, James Spicer
Research output: Contribution to journal › Article › peer-review
25
Scopus
citations